GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$165.61
+4.03%Forward multiples
Based on analyst estimates
- P/E forward
- 17.97x
- P/E 2026E
- —
- P/E 2027E
- 16.23x
- P/E 2028E
- 14.97x
- P/S forward
- 6.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.36x
- Price / sales
- 6.74x
- Price / cash flow
- 15.15x
Enterprise value
- Enterprise value
- $228.3B
- EV / sales
- 7.50x
- EV / EBITDA
- 171.16x
- EV / EBIT
- -152.94x
- Market cap
- $205.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026